Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Probiotics versus bismuth subsalicylate versus placebo for abdominal bloating
IRCT20200601047621N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Jul 2020
- Modality
- Small Molecules, Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of FamiLact, bismuth subsalicylate and Placebo-COD Research Private Ltd in abdominal bloating (3 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoint: Abdominal bloating. Started Jul 2020; status: completed.
02
Drugs
FamiLactbismuth subsalicylatePlacebo-COD Research Private Ltd
03
Conditions
abdominal bloating
Beyond the preview
Go deeper on IRCT20200601047621N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200601047621N1.